首页> 外国专利> STUDY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE IV748 SUBTYPE A FOR DIAGNOSTIC AND VACCINE DRUGS

STUDY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE IV748 SUBTYPE A FOR DIAGNOSTIC AND VACCINE DRUGS

机译:诊断和疫苗接种的人类免疫缺陷病毒IV748 A型亚型的研究

摘要

The invention relates to the field of Virology and biotechnology and can be used to obtain diagnostic and experimental vaccine preparations. A new strain of human immunodeficiency virus IV748, isolated in the territory of the Russian Federation from a patient who did not receive ARV therapy, was described; the route of infection is sexual (heterosexual contact). It belongs to the HIV subtype A variant currently circulating in most of the territory of the Russian Federation. Genetic analysis of the nucleotide sequences of the reverse transcriptase gene, protease gene and integrase gene using the AmpliSense HIV-Resist-Seq reagent kit showed that this virus strain belongs to subtype A and does not contain mutations of resistance to antiretroviral drugs. Possesses stable reproductive activity. The infectious titer is 6 lg TCD 50. It is proposed for use as a physiologically acceptable means for an effective and highly accurate study of the antiviral effect of new generation chemotherapy drugs and for the creation of a vaccine.
机译:本发明涉及病毒学和生物技术领域,可用于获得诊断性和实验性疫苗制剂。描述了一种新的人类免疫缺陷病毒IV748株,该株在俄罗斯联邦境内从未接受抗逆转录病毒疗法的患者中分离出来;感染途径是性接触(异性接触)。它属于目前在俄罗斯联邦大部分地区流行的艾滋病毒A型亚型。使用AmpliSense HIV-Resist-Seq试剂盒对逆转录酶基因,蛋白酶基因和整合酶基因的核苷酸序列进行了遗传分析,结果表明该病毒株属于A亚型,不包含对抗逆转录病毒药物的抗性突变。具有稳定的生殖活动。传染性滴度为6 lg TCD50。被提议作为一种生理学上可接受的手段,用于有效,高度准确地研究新一代化学疗法药物的抗病毒作用并产生疫苗。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号